Lunar results show moderate growth

Article

Bone densitometry firm Lunar of Madison, WI, released financial results for its fourth quarter (end-June) that showed a respectable 9% increase in revenue. The company appears to have enjoyed a slightly better quarter than competitor Hologic, which saw

Bone densitometry firm Lunar of Madison, WI, released financial results for its fourth quarter (end-June) that showed a respectable 9% increase in revenue. The company appears to have enjoyed a slightly better quarter than competitor Hologic, which saw its revenues climb only 3%.

For the quarter, Lunar had revenues of $22.2 million, compared with $20.3 million in the fourth quarter of 1996. The company enjoyed net income of $3.6 million, compared with a profit of $3.1 million in the same period of 1996. For the year, Lunar had sales of $81.5 million, up 22% compared with $66.9 million in 1996. The company finished fiscal 1997 with a net profit of $14.3 million, compared with net income of $9.2 million the year before.

Lunar president Dr. Richard Mazess reported that the company is enjoying continued strong demand for its DPIX-IQ x-ray densitometer, particularly in the U.S. The company said that sales of its Artoscan MRI systems and Orca mini-C-arms increased as well, with revenues from both these product lines climbing 42% to $9.1 million for the year.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.